[{"address1": "12730 High Bluff Drive", "address2": "Suite 400", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 500 8800", "website": "https://kuraoncology.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. Its lead product candidate includes ziftomenib, a selective investigational inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a selective investigational FTI for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification; strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize its oral menin inhibitor for the treatment of patients with acute myeloid leukemia (AML) and other hematologic malignancies; and a clinical collaboration with Mirati Therapeutics, Inc. to evaluate the combination of KO-2806 and adagrasib, a KRASG12C inhibitor in patients with NSCLC. The company is headquartered in San Diego, California.", "fullTimeEmployees": 192, "companyOfficers": [{"maxAge": 1, "name": "Dr. Troy Edward Wilson J.D., Ph.D.", "age": 55, "title": "Chairman, CEO & President", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1296258, "exercisedValue": 1234936, "unexercisedValue": 15624}, {"maxAge": 1, "name": "Ms. Kathleen  Ford", "age": 77, "title": "Chief Operating Officer", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 868935, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Teresa Brophy Bair Esq., J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 745021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Doyle", "age": 53, "title": "Senior Vice President of Finance & Accounting", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francis J. Burrows Ph.D.", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Greg  Mann", "title": "Senior Vice President of Investor Relations & Corporate Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Roger  Bakale Ph.D.", "title": "Senior Vice President of Manufacturing & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maureen  Clancy M.B.A.", "title": "VP and Global Head of Program Leadership & Project Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mollie  Leoni M.D.", "age": 46, "title": "Chief Medical Officer", "yearBorn": 1978, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian T. Powl M.B.A., M.S.", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.98, "open": 12.02, "dayLow": 11.6424, "dayHigh": 12.1, "regularMarketPreviousClose": 11.98, "regularMarketOpen": 12.02, "regularMarketDayLow": 11.6424, "regularMarketDayHigh": 12.1, "payoutRatio": 0.0, "beta": 0.21, "forwardPE": -4.475655, "volume": 1274758, "regularMarketVolume": 1274758, "averageVolume": 1919184, "averageVolume10days": 1426710, "averageDailyVolume10Day": 1426710, "bid": 8.85, "ask": 15.5, "bidSize": 2, "askSize": 2, "marketCap": 1039859328, "fiftyTwoWeekLow": 5.41, "fiftyTwoWeekHigh": 12.49, "allTimeHigh": 43.0, "allTimeLow": 2.5, "priceToSalesTrailing12Months": 9.99586, "fiftyDayAverage": 10.3035, "twoHundredDayAverage": 7.62715, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 509660352, "profitMargins": -2.0848398, "floatShares": 64213707, "sharesOutstanding": 87017518, "sharesShort": 8744761, "sharesShortPriorMonth": 10610088, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.1005, "heldPercentInsiders": 0.01969, "heldPercentInstitutions": 0.97536004, "shortRatio": 3.82, "shortPercentOfFloat": 0.1007, "impliedSharesOutstanding": 87017518, "bookValue": 2.787, "priceToBook": 4.2877645, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -216884000, "trailingEps": -2.48, "forwardEps": -2.67, "enterpriseToRevenue": 4.899, "enterpriseToEbitda": -2.133, "52WeekChange": 0.13770175, "SandP52WeekChange": 0.13287461, "quoteType": "EQUITY", "currentPrice": 11.95, "targetHighPrice": 76.0, "targetLowPrice": 16.0, "targetMeanPrice": 33.0, "targetMedianPrice": 28.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 549665024, "totalCashPerShare": 6.317, "ebitda": -238984992, "totalDebt": 19466000, "quickRatio": 4.828, "currentRatio": 5.117, "totalRevenue": 104029000, "debtToEquity": 8.026, "revenuePerShare": 1.19, "returnOnAssets": -0.26569998, "returnOnEquity": -0.65099996, "grossProfits": -49353000, "freeCashflow": -104869872, "operatingCashflow": 87800000, "grossMargins": -0.47442, "ebitdaMargins": -2.29729, "operatingMargins": -3.8552802, "financialCurrency": "USD", "symbol": "KURA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": -0.20752592, "postMarketPrice": 11.9252, "postMarketChange": -0.024799347, "regularMarketChange": -0.0299997, "regularMarketDayRange": "11.6424 - 12.1", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1919184, "fiftyTwoWeekLowChange": 6.54, "fiftyTwoWeekLowChangePercent": 1.2088724, "fiftyTwoWeekRange": "5.41 - 12.49", "fiftyTwoWeekHighChange": -0.53999996, "fiftyTwoWeekHighChangePercent": -0.043234587, "fiftyTwoWeekChangePercent": 13.770175, "earningsTimestamp": 1762263000, "earningsTimestampStart": 1762263000, "earningsTimestampEnd": 1762263000, "earningsCallTimestampStart": 1762261200, "earningsCallTimestampEnd": 1762261200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.48, "epsForward": -2.67, "epsCurrentYear": -2.33889, "priceEpsCurrentYear": -5.109261, "fiftyDayAverageChange": 1.6464996, "fiftyDayAverageChangePercent": 0.15980002, "twoHundredDayAverageChange": 4.3228498, "twoHundredDayAverageChangePercent": 0.5667713, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1764981006, "regularMarketTime": 1764968401, "exchange": "NMS", "messageBoardId": "finmb_282774456", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Kura Oncology, Inc.", "longName": "Kura Oncology, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1442410200000, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -0.250415, "regularMarketPrice": 11.95, "displayName": "Kura Oncology", "trailingPegRatio": null, "__fetch_time": "2025-12-06"}]